218
Views
10
CrossRef citations to date
0
Altmetric
Review

Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma

, &
Pages 523-530 | Published online: 04 Dec 2014

References

  • BurrJMMowattGHernándezRThe clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluationHealth Technol Assess200711411190
  • QuigleyHABromanATThe number of people with glaucoma worldwide in 2010 and 2020Br J Ophthalmol200690326226716488940
  • QuigleyHANumber of people with glaucoma worldwideBr J Ophthalmol19968053893938695555
  • HattSWormaldRBurrJScreening for prevention of optic nerve damage due to chronic open angle glaucomaCochrane Database Syst Rev20064CD00612917054274
  • HeijlALeskeMCBengtssonBEarly Manifest Glaucoma Trial GroupReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol20021201268127912365904
  • BagnisAPapadiaMScottoRTraversoCECurrent and emerging medical therapies in treatment of glaucomaExpert Opin Emerg Drugs201116229330721406029
  • VassCHirnCSychaTFindlOBauerPSchmettererLMedical interventions for primary open angle glaucoma and ocular hypertensionCochrane Database Syst Rev20074CD00316717943780
  • National Collaborating Centre for Acute Care (UK)Glaucoma: Diagnosis and Management of Chronic Open Angle Glaucoma and Ocular HypertensionLondonNICE Clinical Guidelines, No 852009
  • RachmielRTropeGEChipmanMLGouwsPBuysYMEffect of medical therapy on glaucoma filtration surgery rates in OntarioArch Ophthalmol2006124101472147717030716
  • SamplesJRSinghKLinSCLaser trabeculoplasty for open angle glaucoma: a report by the American Academy of OphthalmologyOphthalmology2011118112296230221849211
  • BrancatoRCarassaRTrabucchiGDiode laser compared with argon laser for trabeculoplastyAm J Ophthalmol1991112150551882922
  • ChungPYSchumanJSNetlandPALloyd-MuhammadRAJacobsDSFive-year results of a randomized, prospective, clinical trial of diode vs argon laser trabeculoplasty for open-angle glaucomaAm J Ophthalmol199812621851909727511
  • BabighianSCarettiLTavolatoMCianRGalanAExcimer laser trabeculotomy vs 180 degrees selective laser trabeculoplasty in primary open-angle glaucoma. A 2-year randomized, controlled trialEye (Lond)201024463263819590523
  • BergeåBBodinLSvedberghBPrimary argon laser trabeculoplasty. III. Long term effects on visual fieldsActa Ophthalmol Scand1995732072157493230
  • Glaucoma Laser Trial Research Group (1995): The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow-up Study. 7. ResultsAm J Ophthalmo1995120718731
  • McIlraithIStrasfeldMColevGHutnikCMSelective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucomaJ Glaucoma20061521243016633226
  • NagarMLuhishiEShahNIntraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplastyBr J Ophthalmol200993449750119106150
  • KimHYEgbertPRSinghKLong-term comparison of primary trabeculectomy with 5-fluorouracil versus mitomycin C in West AfricaJ Glaucoma200817757858318854737
  • BroadwayDMurdochIGlaucoma in blacksEl SayyadFThe Refractory GlaucomasNew YorkIgaku-Shoin Medical Publishers19953154
  • SinghKEgbertPRByrdSTrabeculectomy with intraoperative 5-fluorouracil vs mitomycin CAm J Ophthalmol1997123148539186096
  • KirwanJFCousensSVenterLEffect of beta radiation on success of glaucoma drainage surgery in South Africa: randomised controlled trialBMJ2006333757594217023435
  • WormaldRWilkinsMRBunceCPostoperative 5-Fluorouracil for glaucoma surgeryCochrane Database Syst Rev20013CD00113211686977
  • BurrJAzuara-BlancoAAvenellATuulonenAMedical versus surgical interventions for open angle glaucomaCochrane Database Syst Rev20129CD00439922972069
  • VasudevanSKGuptaVCrowstonJGNeuroprotection in glaucomaIndian J Ophthalmol201159SupplS102S11321150020
  • InoueTTaniharaHRho-associated kinase inhibitors: a novel glaucoma therapyProg Retin Eye Res20133711223770081
  • SimonensSPublic health and prevention in Europe: is it cost-effective? Journal of Pharmaceutical Health Services ResearchJournal of Pharmaceutical Health Services and Research20112151155
  • AinsworthJRJayJLCost analysis of early trabeculectomy versus conventional management in primary open angle glaucomaEye (Lond)19915Pt 33223281955055
  • GuedesRAGuedesVMChaoubahACost-effectiveness comparison between non-penetrating deep sclerectomy and maximum-tolerated medical therapy for glaucoma within the Brazilian National Health System (SUS)Arq Bras Oftalmol2012751111522552410
  • SteinJDKimDDPeckWWGiannettiSMHuttonDWCost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucomaArch Ophthalmol2012130449750522332202
  • WittenbornJSReinDBCost-effectiveness of glaucoma interventions in Barbados and GhanaOptom Vis Sci201188115516321076360
  • WiafeBEconomics of surgery worldwide: Developing countriesShaarawyTSherwoodMBHitchingsRACrowstonJGGlaucoma Volume 2: Surgical ManagementPhiladelphiaSaunder Elsevier2009
  • OmotiAEA review of the choice of therapy in primary open angle glaucomaNiger J Clin Pract6200581293416392453
  • OmotiAEEdemaOTAkpeBAMusaPCost Analysis of Medical versus Surgical Management of Glaucoma in NigeriaJ Ophthalmic Vis Res20105423223922737367
  • RahmanMQBeardSMDiscombeRSharmaRMontgomeryDMDirect healthcare costs of glaucoma treatmentBr J Ophthalmol201397672072423590855
  • AinsworthJRJayJLCost analysis of early trabeculectomy versus conventional management in primary open angle glaucomaEye (Lond)1991533223281955055
  • RoulandJFBerdeauxGLafumaAThe economic burden of glaucoma and ocular hypertension: implications for patient management: a reviewDrugs Aging200522431532115839720
  • AdioAOOnuaAAEconomic burden of glaucoma in Rivers State, NigeriaClin Ophthalmol201262023203123271881
  • WHOMacroeconomics and Health: Investing in Health for Economic DevelopmentReport of Commission of Macroeconomics and HealthWorld Health OrganisationSwitzerland Available from http://whqlibdoc.who.int/publications/2001/924154550x.pdfAccessed March 28, 2014
  • United Nations Development ProgrammeHuman Development Report 2006: Beyond scarcity: Power, poverty and the global water crisisNew YorkUnited Nations Development Programme2006 Available from http://hdr.undp.org/en/content/human-development-report-2006Accessed March 28, 2014
  • RamchandaniMGlaucoma in the developing world: The balance between benefits and harms of surgery varies in different settingsBMJ2006333757593217082526
  • QuigleyHBuhrmannRWestSIssemeIScudderMOlivaMLong term results of glaucoma surgery among participants in an east African population surveyBr J Ophthalmol200084886086410906092
  • SchmierJKHalpernMTJonesMLThe economic implications of glaucoma: a literature reviewPharmacoeconomics200725428730817402803
  • TraversoCEWaltJGKellySPDirect costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in EuropeBr J Ophthalmol200589101245124916170109
  • HirschJDConsiderations in the Pharmacoeconomics of GlaucomaManag Care200211Suppl 11323715357537
  • SharmaAJofre-BonetMPancaMLawrensonJGMurdochIAn economic comparison of hospital-based and community-based glaucoma clinicsEye (Lond)7201226796797122562188
  • OrmeMCollinsSLoftusJLong-term medical management of primary open-angle glaucoma and ocular hypertension in the UK: optimizing cost-effectiveness and clinic resources by minimizing therapy switchesJ Glaucoma201221743344921677590
  • GraySFSpryPGBrookesSTThe Bristol shared care glaucoma study: outcome at follow up at 2 yearsBr J Ophthalmol200084545646310781507
  • BaudouinCRenardJPNordmannJPPrevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertensionEur J Ophthalmol20132314754
  • MurataHHirasawaHAoyamaYIdentifying areas of the visual field important for quality of life in patients with glaucoma201383e58695
  • PisellaPJPouliquenPBaudouinCPrevalence of ocular symptoms and signs with preserved and preservative free glaucoma medicationBr J Ophthalmol200286441842311914211
  • LeungEWMedeirosFWeinrebRNPrevalence of ocular surface disease in glaucoma patientsJ Glaucoma200817535035518703943
  • ZhouCQianSWuPQiuCQuality of life of glaucoma patients in China: sociodemographic, clinical, and psychological correlates – a cross-sectional studyQual Life Res2014233999100824062238
  • UusitaloHChenEPfeifferNSwitching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medicationActa Ophthalmol201088332933620546237
  • OdbergTJakobsenJEHultgrenSJHalseideRThe impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaireActa Ophthalmol Scand200179211612011284746
  • OlthoffCMSchoutenJSvan de BorneBWWebersCANoncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based reviewOphthalmology2005112695366115885795
  • MansbergerSLShepplerCRMcClureTMPsychometrics of a new questionnaire to assess glaucoma adherence: the Glaucoma Treatment Compliance Assessment Tool (an American Ophthalmological Society thesis)Trans Am Ophthalmol Soc201311111624072942
  • KulkarniSVDamjiKFBuysYMMedical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistencyPatient Prefer Adherence2008230331419920977
  • LeiteMTSakataLMMedeirosFAManaging glaucoma in developing countriesArq Bras Oftalmol2011742838421779659